Privacy Policy | XOLAIR® (Omalizumab)

IMPORTANT SAFETY INFORMATION
SCROLL FOR MORE

Genentech, Inc. (“Genentech”) and Novartis Pharmaceuticals, Inc. respect the privacy of visitors to this website, and we recognize your need for appropriate protection and management of personally identifiable information you share with us (any information by which you can be identified, including but not limited to, name, address, e-mail address, and telephone number). That is why we have established this Privacy Policy, so that you are informed about how we treat any personally identifiable information that you provide to us in the course of using this website. This Privacy Policy will inform you of:

How you will be informed of updates to this Privacy Policy
What personally identifiable information of yours we may collect from you through our website
How we may use your personally identifiable information
Limits on how we would share and disclose your personally identifiable information
Our policy regarding links to third party websites
Security of our website
How you can correct and update your personally identifiable information

Please note that the Genentech and Novartis websites are directed towards users who reside in the United States of America. It is not our intent to gather personally identifiable information from individuals residing outside the U.S.

Privacy Policy Updates
Due to the Internet's rapidly evolving nature, Genentech and Novartis may need to update this Privacy Policy from time to time. If so, Genentech and Novartis will post their updated Privacy Policy on our website located here so users are always aware of what personally identifiable information we may collect and how we may use this information. Genentech and Novartis encourage you to review this Privacy Policy regularly for any changes. Your continued use of this website will be subject to the then-current Privacy Policy.

Information Collection and Use
You can generally visit our website without revealing any personally identifiable information about yourself. However, to access certain options and services we may ask you to provide certain personally identifiable information and without providing such personally identifiable information, you may be unable to access certain options and services. We (along with our third party partners engaged to provide marketing and advertising on our behalf) collect personally identifiable information about you only if you voluntarily provide it to us and you have the option not to provide any personally identifiable information to us. The following is personally identifiable information that you may voluntarily provide to us and how we use it:

Surveys. Information obtained from you on web surveys, such as contact information (name and shipping address), demographic information (zip code, age level) and medical condition. We may use this personally identifiable information to provide you with information and services for which you have expressed an interest or that you may find useful based on your answers in a survey. Additionally, we may refer to your personally identifiable information to better understand your needs and how we can improve our website.
Newsletters. Information obtained from you from your request to subscribe to a newsletter, such as contact information (name and email address). We may use this personally identifiable information to deliver the newsletters that you have elected to receive.
Registration. Information obtained from you on registration forms used to process your requests for services and information, such as contact information (name, address, email address), password, username or code, age, date of birth, gender, ethnicity and medical condition. This registration information may also be gathered if you register for certain services via fax or mail. We may use this information to send you a welcoming email to verify your username and password, website updates, special offers, notices regarding relevant medical conditions and treatment, or other information responsive to the data that you provide to us. Additionally, we may refer to your personally identifiable information to better understand your needs and how we can improve our website.
Employment. Information obtained from you on registration forms to process your requests to create an account to access job postings and to post your resume, such as contact information (name, email address, mailing address), password, username or code, employment history and any other personally identifiable information contained in your resume that you post to the website. We may use your personally identifiable information to send you a welcoming email to verify your username and password, for employee recruitment purposes and to respond to your requests for information.
E-mail Content to a Friend. Information obtained from you regarding friend or family name and email address, if you elect to use our referral service for sending some of our website content to friends and family. We may use this personally identifiable information to automatically send the friend or family member a one-time email inviting them to visit the website. We may store this information for the sole purpose of sending this one-time email.

Genentech and Novartis are the owners of all information collected on this website.

Minors
You must be 18 years of age of older to submit registration or survey information. If you are under and wish to register to obtain further information or be included in a survey, then your parent of legal guardian must register to obtain the information or to participate in the survey.

Privacy Statement for Children
Our websites are not intended for designed to attract children under the age of 13. Moreover, we do not knowingly collect any personally identifiable information from anyone under the age of 18 without the consent of the parent or guardian. Should you believe that a minor for which you are a parent or guardian has registered, please contact us at privacy.office@gene.com and we will make reasonable efforts to remove all personally identifiable information related to the minor.

Cookies and GIF files
Some of our websites may use cookie technology to identify users who have previously visited so the user is recognized upon return, thereby saving them time while on our website. A cookie is a piece of data stored on the user's hard drive containing information about the user. Usage of a cookie is in no way linked to any personally identifiable information while on our website. Once the user closes their browser, the cookie simply terminates. If a user rejects the cookie, they may still use our website. A cookie may be placed by us, or by vendors or service agencies who work with us or with our partners. This website may use pixels, or transparent GIF files, to help manage online advertising. These GIF files are provided by our ad management partners. These files enable these partners to recognize a unique file on your web browser, which in turn enables us to learn which advertisements bring users to our website. The information contained in GIF files that we collect and share with our ad management partners is anonymous and is not personally identifiable.

Log Files and Aggregate Information
We may track the total number of visitors to our website, the number of visitors to each page of our website, IP addresses, and the domain names of our users' Internet Service Providers, and we may analyze these data for trends and statistics in the aggregate, but such information will be in aggregate form only and it will not contain personally identifiable data. Such aggregate information is not linked to any personally identifiable information that can identify any individual person. We may use such aggregate information to analyze trends, administer the website, track user's movement, and gather broad demographic information for aggregate use. We may share this aggregate information with our corporate partners and contracted vendors to assist us in operating the website and to enable them to better understand Genentech and Novartis's business.

Sharing and Disclosure
We may provide your personally identifiable information that we collect and the data generated by cookies to a parent, subsidiary or affiliate entity within the Genentech and Novartis corporate family, partner entities, and the vendors and service agencies that we may engage to assist us. For example, we may provide your personally identifiable information to an organization in order to complete a service (e.g., send out newsletter e-mails you have requested), to assist us in reviewing the data or to provide marketing or advertising on our behalf. Any organization to which we provide such personally identifiable information is also required to keep your personally identifiable information confidential in accordance with this Privacy Policy. We will also disclose your personally identifiable information if we reasonably believe we are required to do so by law, regulation or other government authority (such as reporting safety information to the Food and Drug Administration). We will not sell your personally identifiable information to any other company or organization except we may transfer your personally identifiable information to a successor entity upon a merger, consolidation or other corporate reorganization in which Genentech and Novartis participate or to a purchaser of all or substantially all of Genentech and Novartis's assets. Such successor entity shall be bound by the terms and conditions of this Privacy Policy.

Links to Third Party Sites
Some of our websites may contain links to other websites on the Internet that are not under the control of or maintained by Genentech and Novartis. Such links do not constitute an endorsement by Genentech and Novartis of those other websites, the content displayed therein, or the persons or entities associated therewith. You acknowledge that Genentech and Novartis are providing these links to you only as a convenience, and you agree that Genentech and Novartis is not responsible for the content of such websites. Your use of these other linked websites is subject to the respective terms of use and privacy policies located on the linked websites.

Security
Genentech, Novartis, and their third party providers may employ procedural and technological security measures, consistent with industry practice. Such measures are reasonably designed to protect your personally identifiable information from loss, unauthorized access, disclosure, alteration or destruction. Genentech and Novartis may use encryption, password protection, secure socket layers, internal restrictions and other security measures to help prevent unauthorized access to your personally identifiable information.

Correction/Updating Personally Identifiable Information
Genentech and Novartis provide you with the ability to review and correct any of the personally identifiable information that you have provided to us. If you wish to correct any information provided to us, you may update your contact information directly by accessing your account or registration. You may also "opt-out" of receiving emails and other communications from us by using the unsubscribe feature included in the emails we send.

Who is XOLAIR for?

XOLAIR^® (omalizumab) for subcutaneous use is an injectable, prescription medicine for patients 12 years of age and older. It is for patients with moderate to severe persistent allergic asthma caused by year-round allergens in the air. A skin or blood test is done to see if you have allergic asthma. XOLAIR is for patients who are not controlled by asthma medicines called inhaled steroids.

XOLAIR helps reduce the number of asthma attacks in people with allergic asthma who still have asthma symptoms even though they are taking inhaled steroids.

Important Limitations of Use

XOLAIR has not been proven to work in other allergic conditions
XOLAIR is not a rescue medicine and should not be used to treat sudden asthma attacks
XOLAIR should not be used in children under 12 years of age

IMPORTANT SAFETY INFORMATION

XOLAIR should always be injected in a doctor's office. You should read the Medication Guide before starting XOLAIR treatment and before each and every treatment.

A severe allergic reaction called anaphylaxis has happened in some patients after they received XOLAIR. Anaphylaxis is a life-threatening condition and can lead to death, so get emergency medical treatment right away if signs or symptoms of anaphylaxis occur after receiving XOLAIR.

Signs and symptoms of anaphylaxis include:

wheezing, shortness of breath, cough, chest tightness, or trouble breathing
low blood pressure, dizziness, fainting, rapid or weak heartbeat, anxiety, or feeling of "impending doom"
flushing, itching, hives, or feeling warm
swelling of the throat or tongue, throat tightness, hoarse voice, or trouble swallowing

Anaphylaxis from XOLAIR can happen:

right after receiving a XOLAIR injection or hours later
after any XOLAIR injection. Anaphylaxis has occurred after the first XOLAIR injection or after many XOLAIR injections.

Your healthcare provider should watch you for some time in the office for signs or symptoms of anaphylaxis after injecting XOLAIR. If you have signs or symptoms of anaphylaxis, tell your healthcare provider right away.

You should not receive XOLAIR if you have ever had an allergic reaction to a XOLAIR injection. Do not use XOLAIR if you are allergic to any of its ingredients.

In clinical studies, a variety of cancer types, including breast, skin, prostate, and parotid (a type of salivary gland), were reported in more patients who received XOLAIR than in patients who did not receive XOLAIR.

XOLAIR is not a rescue medicine and should not be used to treat sudden asthma attacks.

XOLAIR is not a substitute for the medicines you are already taking. Do not change or stop taking any of your other asthma medicines unless your doctor tells you to do so.

Some patients on XOLAIR may have an abnormal increase in eosinophils (a type of white blood cell) in the blood or tissues, sometimes causing an inflammation of blood vessels, which can lead to rash, worsening of respiratory symptoms, heart trouble, and/or nerve pain and weakness.

Joint inflammation or pain, rash, fever, and swollen lymph nodes have been seen in some patients taking XOLAIR, after the first or subsequent injections. Talk to your doctor if you've experienced any of these signs and symptoms.

The most commonly seen side effects occurring more frequently in patients receiving XOLAIR than in patients who received placebo (an injection with no active medicine) were joint pain, pain (general), leg pain, tiredness (fatigue), dizziness, fracture, arm pain, itching, inflammation of the skin, and earache.

In asthma studies, the most common side effects in patients, who either needed to stop XOLAIR or needed medical attention, were injection site reaction, viral infections, upper respiratory tract infection, sinusitis, headache, and sore throat. These side effects were seen at similar rates in XOLAIR-treated patients as in patients that did not receive XOLAIR.

There are other possible side effects with XOLAIR. Talk to your doctor for more information and if you have any questions about your treatment.

XOLAIR has not been studied in pregnant women. Pregnant women exposed to XOLAIR are encouraged to enroll in the XOLAIR Pregnancy Exposure Registry. You can get more information by calling 1-866-4XOLAIR (1-866-496-5247) or by speaking with your doctor.

Please see full Prescribing Information, including Medication Guide for additional important safety information.

A A A For Healthcare Professionals Important Safety Information Full Prescribing Information Share Text size SEARCH You are leaving XOLAIR.com The information contained in this section of the site is intended for U.S healthcare professionals only. Are you a U.S. healthcare professional? Please note XOLAIR is not affiliated with this website and is not responsible for its content. Browser Upgrade Required To view XOLAIR.com, you'll need Internet Explorer version 8. Simply click OK to download it now.
	Print this page >> Advanced Search IMPORTANT SAFETY INFORMATION SCROLL FOR MORE Genentech, Inc. (“Genentech”) and Novartis Pharmaceuticals, Inc. respect the privacy of visitors to this website, and we recognize your need for appropriate protection and management of personally identifiable information you share with us (any information by which you can be identified, including but not limited to, name, address, e-mail address, and telephone number). That is why we have established this Privacy Policy, so that you are informed about how we treat any personally identifiable information that you provide to us in the course of using this website. This Privacy Policy will inform you of: How you will be informed of updates to this Privacy Policy What personally identifiable information of yours we may collect from you through our website How we may use your personally identifiable information Limits on how we would share and disclose your personally identifiable information Our policy regarding links to third party websites Security of our website How you can correct and update your personally identifiable information Please note that the Genentech and Novartis websites are directed towards users who reside in the United States of America. It is not our intent to gather personally identifiable information from individuals residing outside the U.S. Privacy Policy Updates Due to the Internet's rapidly evolving nature, Genentech and Novartis may need to update this Privacy Policy from time to time. If so, Genentech and Novartis will post their updated Privacy Policy on our website located here so users are always aware of what personally identifiable information we may collect and how we may use this information. Genentech and Novartis encourage you to review this Privacy Policy regularly for any changes. Your continued use of this website will be subject to the then-current Privacy Policy. Information Collection and Use You can generally visit our website without revealing any personally identifiable information about yourself. However, to access certain options and services we may ask you to provide certain personally identifiable information and without providing such personally identifiable information, you may be unable to access certain options and services. We (along with our third party partners engaged to provide marketing and advertising on our behalf) collect personally identifiable information about you only if you voluntarily provide it to us and you have the option not to provide any personally identifiable information to us. The following is personally identifiable information that you may voluntarily provide to us and how we use it: Surveys. Information obtained from you on web surveys, such as contact information (name and shipping address), demographic information (zip code, age level) and medical condition. We may use this personally identifiable information to provide you with information and services for which you have expressed an interest or that you may find useful based on your answers in a survey. Additionally, we may refer to your personally identifiable information to better understand your needs and how we can improve our website. Newsletters. Information obtained from you from your request to subscribe to a newsletter, such as contact information (name and email address). We may use this personally identifiable information to deliver the newsletters that you have elected to receive. Registration. Information obtained from you on registration forms used to process your requests for services and information, such as contact information (name, address, email address), password, username or code, age, date of birth, gender, ethnicity and medical condition. This registration information may also be gathered if you register for certain services via fax or mail. We may use this information to send you a welcoming email to verify your username and password, website updates, special offers, notices regarding relevant medical conditions and treatment, or other information responsive to the data that you provide to us. Additionally, we may refer to your personally identifiable information to better understand your needs and how we can improve our website. Employment. Information obtained from you on registration forms to process your requests to create an account to access job postings and to post your resume, such as contact information (name, email address, mailing address), password, username or code, employment history and any other personally identifiable information contained in your resume that you post to the website. We may use your personally identifiable information to send you a welcoming email to verify your username and password, for employee recruitment purposes and to respond to your requests for information. E-mail Content to a Friend. Information obtained from you regarding friend or family name and email address, if you elect to use our referral service for sending some of our website content to friends and family. We may use this personally identifiable information to automatically send the friend or family member a one-time email inviting them to visit the website. We may store this information for the sole purpose of sending this one-time email. Genentech and Novartis are the owners of all information collected on this website. Minors You must be 18 years of age of older to submit registration or survey information. If you are under and wish to register to obtain further information or be included in a survey, then your parent of legal guardian must register to obtain the information or to participate in the survey. Privacy Statement for Children Our websites are not intended for designed to attract children under the age of 13. Moreover, we do not knowingly collect any personally identifiable information from anyone under the age of 18 without the consent of the parent or guardian. Should you believe that a minor for which you are a parent or guardian has registered, please contact us at privacy.office@gene.com and we will make reasonable efforts to remove all personally identifiable information related to the minor. Cookies and GIF files Some of our websites may use cookie technology to identify users who have previously visited so the user is recognized upon return, thereby saving them time while on our website. A cookie is a piece of data stored on the user's hard drive containing information about the user. Usage of a cookie is in no way linked to any personally identifiable information while on our website. Once the user closes their browser, the cookie simply terminates. If a user rejects the cookie, they may still use our website. A cookie may be placed by us, or by vendors or service agencies who work with us or with our partners. This website may use pixels, or transparent GIF files, to help manage online advertising. These GIF files are provided by our ad management partners. These files enable these partners to recognize a unique file on your web browser, which in turn enables us to learn which advertisements bring users to our website. The information contained in GIF files that we collect and share with our ad management partners is anonymous and is not personally identifiable. Log Files and Aggregate Information We may track the total number of visitors to our website, the number of visitors to each page of our website, IP addresses, and the domain names of our users' Internet Service Providers, and we may analyze these data for trends and statistics in the aggregate, but such information will be in aggregate form only and it will not contain personally identifiable data. Such aggregate information is not linked to any personally identifiable information that can identify any individual person. We may use such aggregate information to analyze trends, administer the website, track user's movement, and gather broad demographic information for aggregate use. We may share this aggregate information with our corporate partners and contracted vendors to assist us in operating the website and to enable them to better understand Genentech and Novartis's business. Sharing and Disclosure We may provide your personally identifiable information that we collect and the data generated by cookies to a parent, subsidiary or affiliate entity within the Genentech and Novartis corporate family, partner entities, and the vendors and service agencies that we may engage to assist us. For example, we may provide your personally identifiable information to an organization in order to complete a service (e.g., send out newsletter e-mails you have requested), to assist us in reviewing the data or to provide marketing or advertising on our behalf. Any organization to which we provide such personally identifiable information is also required to keep your personally identifiable information confidential in accordance with this Privacy Policy. We will also disclose your personally identifiable information if we reasonably believe we are required to do so by law, regulation or other government authority (such as reporting safety information to the Food and Drug Administration). We will not sell your personally identifiable information to any other company or organization except we may transfer your personally identifiable information to a successor entity upon a merger, consolidation or other corporate reorganization in which Genentech and Novartis participate or to a purchaser of all or substantially all of Genentech and Novartis's assets. Such successor entity shall be bound by the terms and conditions of this Privacy Policy. Links to Third Party Sites Some of our websites may contain links to other websites on the Internet that are not under the control of or maintained by Genentech and Novartis. Such links do not constitute an endorsement by Genentech and Novartis of those other websites, the content displayed therein, or the persons or entities associated therewith. You acknowledge that Genentech and Novartis are providing these links to you only as a convenience, and you agree that Genentech and Novartis is not responsible for the content of such websites. Your use of these other linked websites is subject to the respective terms of use and privacy policies located on the linked websites. Security Genentech, Novartis, and their third party providers may employ procedural and technological security measures, consistent with industry practice. Such measures are reasonably designed to protect your personally identifiable information from loss, unauthorized access, disclosure, alteration or destruction. Genentech and Novartis may use encryption, password protection, secure socket layers, internal restrictions and other security measures to help prevent unauthorized access to your personally identifiable information. Correction/Updating Personally Identifiable Information Genentech and Novartis provide you with the ability to review and correct any of the personally identifiable information that you have provided to us. If you wish to correct any information provided to us, you may update your contact information directly by accessing your account or registration. You may also "opt-out" of receiving emails and other communications from us by using the unsubscribe feature included in the emails we send. Privacy Policy Last updated: February 23, 2011 Who is XOLAIR for? XOLAIR^® (omalizumab) for subcutaneous use is an injectable, prescription medicine for patients 12 years of age and older. It is for patients with moderate to severe persistent allergic asthma caused by year-round allergens in the air. A skin or blood test is done to see if you have allergic asthma. XOLAIR is for patients who are not controlled by asthma medicines called inhaled steroids. XOLAIR helps reduce the number of asthma attacks in people with allergic asthma who still have asthma symptoms even though they are taking inhaled steroids. Important Limitations of Use XOLAIR has not been proven to work in other allergic conditions XOLAIR is not a rescue medicine and should not be used to treat sudden asthma attacks XOLAIR should not be used in children under 12 years of age IMPORTANT SAFETY INFORMATION XOLAIR should always be injected in a doctor's office. You should read the Medication Guide before starting XOLAIR treatment and before each and every treatment. A severe allergic reaction called anaphylaxis has happened in some patients after they received XOLAIR. Anaphylaxis is a life-threatening condition and can lead to death, so get emergency medical treatment right away if signs or symptoms of anaphylaxis occur after receiving XOLAIR. Signs and symptoms of anaphylaxis include: wheezing, shortness of breath, cough, chest tightness, or trouble breathing low blood pressure, dizziness, fainting, rapid or weak heartbeat, anxiety, or feeling of "impending doom" flushing, itching, hives, or feeling warm swelling of the throat or tongue, throat tightness, hoarse voice, or trouble swallowing Anaphylaxis from XOLAIR can happen: right after receiving a XOLAIR injection or hours later after any XOLAIR injection. Anaphylaxis has occurred after the first XOLAIR injection or after many XOLAIR injections. Your healthcare provider should watch you for some time in the office for signs or symptoms of anaphylaxis after injecting XOLAIR. If you have signs or symptoms of anaphylaxis, tell your healthcare provider right away. You should not receive XOLAIR if you have ever had an allergic reaction to a XOLAIR injection. Do not use XOLAIR if you are allergic to any of its ingredients. In clinical studies, a variety of cancer types, including breast, skin, prostate, and parotid (a type of salivary gland), were reported in more patients who received XOLAIR than in patients who did not receive XOLAIR. XOLAIR is not a rescue medicine and should not be used to treat sudden asthma attacks. XOLAIR is not a substitute for the medicines you are already taking. Do not change or stop taking any of your other asthma medicines unless your doctor tells you to do so. Some patients on XOLAIR may have an abnormal increase in eosinophils (a type of white blood cell) in the blood or tissues, sometimes causing an inflammation of blood vessels, which can lead to rash, worsening of respiratory symptoms, heart trouble, and/or nerve pain and weakness. Joint inflammation or pain, rash, fever, and swollen lymph nodes have been seen in some patients taking XOLAIR, after the first or subsequent injections. Talk to your doctor if you've experienced any of these signs and symptoms. The most commonly seen side effects occurring more frequently in patients receiving XOLAIR than in patients who received placebo (an injection with no active medicine) were joint pain, pain (general), leg pain, tiredness (fatigue), dizziness, fracture, arm pain, itching, inflammation of the skin, and earache. In asthma studies, the most common side effects in patients, who either needed to stop XOLAIR or needed medical attention, were injection site reaction, viral infections, upper respiratory tract infection, sinusitis, headache, and sore throat. These side effects were seen at similar rates in XOLAIR-treated patients as in patients that did not receive XOLAIR. There are other possible side effects with XOLAIR. Talk to your doctor for more information and if you have any questions about your treatment. XOLAIR has not been studied in pregnant women. Pregnant women exposed to XOLAIR are encouraged to enroll in the XOLAIR Pregnancy Exposure Registry. You can get more information by calling 1-866-4XOLAIR (1-866-496-5247) or by speaking with your doctor. Please see full Prescribing Information, including Medication Guide for additional important safety information. Privacy Policy Terms and Conditions Site Map Glossary Contact Us ©2011 Genentech USA, Inc. and Novartis Pharmaceuticals Corporation. All rights reserved. This website is a service of Genentech USA, Inc. and Novartis Pharmaceuticals Corporation and is intended for US residents only. XOL0000302502